Hikal Limited (NSE: HIKAL) signs a multi-year global CDMO contract with a leading agrochemical company, marking a key milestone for its Crop Protection busin.
Morepen Laboratories Limited (MOREPENLAB) submits its first U.S. ANDA for Sitagliptin Tablets, enhancing its CDMO capabilities.
Dishman Carbogen Amcis Limited (DCAL) reports Q1FY27 results with net revenue dipping 4.29%, driven by CDMO segment decline.
Sai Life Sciences Limited (SAILIFE) reports Q1 FY27 results with ₹554 crore revenue, up 12% YoY, strong CRO growth and sustained pipeline.
Cohance Lifesciences Limited (COHANCE) reports Q1FY27 financial results, with revenue down 23.1% YoY, expects rebound in H2.
Morepen Laboratories Limited (MOREPENLAB) has initiated commercial supplies under its ₹825 crore CDMO mandate, completing the first ₹50 crore dispatch in Q1F.
Dishman Carbogen Amcis Limited (DCAL) reports a 18.9% revenue increase in Q4 FY26, driven by growth in CDMO and Marketable Molecules segments.
Sai Life Sciences Limited (SAILIFE) reports a 29% revenue increase and a 56% EBITDA rise for FY26, driven by strong execution and strategic investments.